Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
07/12/2006 | CN1802380A Use of vinca alkaloid and its salt |
07/12/2006 | CN1802366A C-glycoside derivatives and salts thereof |
07/12/2006 | CN1802351A Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
07/12/2006 | CN1802350A Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders |
07/12/2006 | CN1802178A Solid formulation |
07/12/2006 | CN1802167A Fusion proteins |
07/12/2006 | CN1802166A Compositions for mucosal and oral administration comprising HCG fragments |
07/12/2006 | CN1800221A Hydroxypropyl- sulfobutyl-beta- cyclodextrin and its preparation method, analytical method and pharmaceutical uses |
07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
07/12/2006 | CN1799604A Calcium-tonifying bone-strengthening medicine and preparation method thereof |
07/12/2006 | CN1799602A Qi-invigorating, yin-nourishing medicinal pills and preparation method thereof |
07/12/2006 | CN1799601A Blood lipid-lowering medicine and preparation method thereof |
07/12/2006 | CN1799594A Medicine for treating cardiovascular and cerebrovascular disease and its preparing process |
07/12/2006 | CN1799582A Blood sugar- and blood pressure-lowering medicine |
07/12/2006 | CN1799571A Medicine for lowering blood sugar and treating women menopausal syndrome and preparation method thereof |
07/12/2006 | CN1799551A Process for preparing glucose injection and glucose sodium chloride injection |
07/12/2006 | CN1799549A Process for preparing soybean isoflavone phospholipid composition |
07/12/2006 | CN1799548A Soybean isoflavone phospholipid composition and preparation method thereof |
07/12/2006 | CN1799542A Hawthorn fruit total flavone phospholipid composition and its preparation method |
07/12/2006 | CN1799541A Soybean isoflavone soft capsule and its preparation process |
07/12/2006 | CN1799410A Diet fiber composition with blood lipid-reducing blood sugar-decreasing functions and its production method |
07/12/2006 | CN1799407A Aloe and pollen tablet and its production method |
07/12/2006 | CN1263842C New type health-care liquid from mashed onion and its preparation method |
07/12/2006 | CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives |
07/12/2006 | CN1263745C Aryl fused azapolycyclic compounds |
07/12/2006 | CN1263734C Acyl-3-carboxyphenylurea derivatives, method for production and use thereof |
07/12/2006 | CN1263513C Emulsifying agent for preparing milky white cod liver oil |
07/12/2006 | CN1263495C Pill for treating diabetes and preparation method thereof |
07/12/2006 | CN1263492C Externally applied medicine for treating diabetes |
07/12/2006 | CN1263489C Therapeutic and health-care medicinal hand bag |
07/12/2006 | CN1263488C Capsule with ginseng and preparing technique |
07/12/2006 | CN1263457C Orally disintegrating tablet of gypenosides and its preparation process |
07/12/2006 | CN1263447C Stable solution of reduced coenzyme Q |
07/12/2006 | CN1263398C Method for preparing vitamin B enriched products from herbal plant |
07/12/2006 | CN1263397C High-calory liquid oral supplement |
07/12/2006 | CN1263389C Tea of whiteflower red root and producing method |
07/11/2006 | US7074940 Preparation of pharmaceutically acceptable atorvastatin salts in non-crystalline forms |
07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
07/11/2006 | US7074925 N-substituted derivatives of 5-oxyiminobarbituric acid |
07/11/2006 | US7074814 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antiarthritic agents ; psoriasis |
07/11/2006 | US7074811 for use in the treatment and/or prophylaxis of diabetes mellitus |
07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
07/11/2006 | US7074802 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents |
07/11/2006 | US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
07/11/2006 | US7074800 Quinazoline derivatives as angiogenesis inhibitors |
07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
07/11/2006 | US7074798 Xanthine derivative and DPPIV inhibitor |
07/11/2006 | US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
07/11/2006 | US7074780 Substituted phenylcyclohexanecarboxamides and their use |
07/11/2006 | US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents |
07/11/2006 | US7074617 MHC class II antigen-presenting systems and methods for activatind CD4+T cells |
07/11/2006 | US7074437 comprises synthetic zeolite, protein extracts of nettle, milk vetch, balm, hop cones, and B-complex vitamins |
07/11/2006 | US7074433 Process for the cure and control of Diabetes mellitus using natural products from Perna viridis |
07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
07/11/2006 | US7074407 immunizing with fragments of CETP (cholesteryl ester transfer protein) which may be conjugated to a carrier, such as KLH (keyhole limpet hemocyanin) or ovalbumin, to increase immunogenicity |
07/11/2006 | US7074406 Treating allergic diseases with humanized anti-CD40L antibody |
07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
07/11/2006 | CA2376876C New isoindoloindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
07/11/2006 | CA2355102C Antiparasitic formulations comprising doramectin |
07/11/2006 | CA2344255C Novel derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane, process for preparing them and pharmaceutical compositions containing them |
07/11/2006 | CA2319201C Celecoxib compositions |
07/11/2006 | CA2294670C Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora |
07/11/2006 | CA2285548C Nicotinamide derivatives |
07/11/2006 | CA2269810C N-substituted 2-cyanopyrrolidines |
07/11/2006 | CA2215233C Terminal carboxy or tetrazole groups containing dialkyl ethers |
07/11/2006 | CA2208630C 4-amino-2-ureidopyrimidine-5-carboxamides, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
07/11/2006 | CA2198751C Dihydro-2,3-benzodiazepine derivatives |
07/11/2006 | CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same |
07/06/2006 | WO2006072054A1 Zinc-containing treatments for hyperphosphatemia |
07/06/2006 | WO2006071752A1 Azolopyrimidine-based inhibitors of dipeptidyl peptidase iv and methods |
07/06/2006 | WO2006071095A1 Quinazoline derivatives for the treatment and prevention of diabetes and obesity |
07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
07/06/2006 | WO2006070874A1 Hypoxic response promoter |
07/06/2006 | WO2006070873A1 Adiponectin inducer or secretagogue |
07/06/2006 | WO2006070856A1 Sesamin/episesamin compositions |
07/06/2006 | WO2006070618A1 Catecholamine regulator and foods, drinks, food additives and drugs containing the same |
07/06/2006 | WO2006070208A1 Pyridine, pyrimidine and pyrazine derivatives as gpcr agonists |
07/06/2006 | WO2006070106A1 N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid cb1 receptor antagonists |
07/06/2006 | WO2006069809A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments |
07/06/2006 | WO2006069807A1 Substituted phenyl-piperazine compounds, their preparation and use in medicaments |
07/06/2006 | WO2006069519A1 Solid dispersion of glibenclamide, its oral composition and methods |
07/06/2006 | WO2006050314A3 Once a day formulation for phosphate binders |
07/06/2006 | WO2006043036A3 Treatment of diabetes |
07/06/2006 | WO2006035286A3 Process for preparating enantiomerically pure fluvastatin sodium and a novel polymorphic form thereof |
07/06/2006 | WO2006030303A8 Oral extended release dosage form comprising a high dose biguanide and a low dose sulfonylurea |
07/06/2006 | WO2005116002A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
07/06/2006 | WO2005077400A8 Cysteine rich peptides for improving thiol homeostasis |
07/06/2006 | US20060149075 Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione |
07/06/2006 | US20060149033 IGF antagonist peptides |
07/06/2006 | US20060148875 Agent for prophylaxis and treatment of diabetic complications |
07/06/2006 | US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
07/06/2006 | US20060148840 Pyrrolodihydroisoquinolines as pde10 inhibitors |
07/06/2006 | US20060148838 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
07/06/2006 | US20060148834 Novel coumarin-amide derivatives and its preparation, said drug composition and its use |
07/06/2006 | US20060148825 1-[Alkyl], 1-[(heteroaryl) alkyl] and 1-[(Aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives |
07/06/2006 | US20060148819 Chemical compounds |
07/06/2006 | US20060148802 Use of compounds that stimulate cgmp |
07/06/2006 | US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents |
07/06/2006 | US20060148794 Neuropeptide Y antagonist; antiarthritic agents; cardiovascular disorders; antidiabetic agents; kidney disorders; eating disorders; obesity |
07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |